When are medication side effects due to the nocebo phenomenon

作者: Elizabeth A. Catlin

DOI: 10.1001/JAMA.287.19.2502

关键词:

摘要:

参考文章(10)
C. L. Loprinzi, N. M. Ellison, D. J. Schaid, J. E. Krook, L. M. Athmann, A. M. Dose, J. A. Mailliard, P. S. Johnson, L. P. Ebbert, L. H. Geeraerts, Controlled Trial of Megestrol Acetate for the Treatment of Cancer Anorexia and Cachexia Journal of the National Cancer Institute. ,vol. 82, pp. 1127- 1132 ,(1990) , 10.1093/JNCI/82.13.1127
Beatrice A. Golomb, Paradox of placebo effect Nature. ,vol. 375, pp. 530- 530 ,(1995) , 10.1038/375530A0
Arthur J. Barsky, Nonspecific Medication Side Effects and the Nocebo Phenomenon JAMA. ,vol. 287, pp. 622- 627 ,(2002) , 10.1001/JAMA.287.5.622
Robert Keeley, Marcia Smith, John Miller, Somatoform Symptoms and Treatment Nonadherence in Depressed Family Medicine Outpatients Archives of Family Medicine. ,vol. 9, pp. 46- 54 ,(2000) , 10.1001/ARCHFAMI.9.1.46
G.R. Corazza, L. Ginaldi, N. Furia, G. Marani-Toro, D. Di Giammartino, D. Quaglino, The impact of HIV infection on lactose absorptive capacity Journal of Infection. ,vol. 35, pp. 31- 35 ,(1997) , 10.1016/S0163-4453(97)90905-1
Irving Kirsch, Lynne J. Weixel, Double-blind versus deceptive administration of a placebo. Behavioral Neuroscience. ,vol. 102, pp. 319- 323 ,(1988) , 10.1037//0735-7044.102.2.319
Robert A. Hahn, The Nocebo Phenomenon: Concept, Evidence, and Implications for Public Health Preventive Medicine. ,vol. 26, pp. 607- 611 ,(1997) , 10.1006/PMED.1996.0124
Kurt Kroenke, Suzanne L. West, Ralph Swindle, Alicia Gilsenan, George J. Eckert, Rowena Dolor, Paul Stang, Xiao-Hua Zhou, Ron Hays, Morris Weinberger, Similar Effectiveness of Paroxetine, Fluoxetine, and Sertraline in Primary Care JAMA. ,vol. 286, pp. 2947- 2955 ,(2001) , 10.1001/JAMA.286.23.2947
Crow, Gage, Hampson, Hart, Kimber, Thomas, The role of expectancies in the placebo effect and their use in the delivery of health care: a systematic review. Health Technology Assessment. ,vol. 3, pp. 1- 96 ,(1999) , 10.3310/HTA3030